Comparison of Antibody Repertoires against Staphylococcus aureus in Healthy Individuals and in Acutely Infected Patients
Open Access
- 1 March 2005
- journal article
- research article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 12 (3) , 387-398
- https://doi.org/10.1128/cdli.12.3.387-398.2005
Abstract
The management of staphylococcal diseases is increasingly difficult with present medical approaches. Preventive and therapeutic vaccination is considered to be a promising alternative; however, little is known about immune correlates of protection and disease susceptibility. To better understand the immune recognition of Staphylococcus aureus by the human host, we studied the antistaphylococcal humoral responses in healthy people in comparison to those of patients with invasive diseases. In a series of enzyme-linked immunosorbent assay analyses performed using 19 recombinant staphylococcal cell surface and secreted proteins, we measured a wide range of antibody levels, finding a pronounced heterogeneity among individuals in both donor groups. The analysis revealed marked differences in the antibody repertoires of healthy individuals with or without S. aureus carriage, as well as in those of patients in the acute phase of infection. Most importantly, we identified antigenic proteins for which specific antibodies were missing or underrepresented in infected patients. In contrast to the well-described transient nature of disease-induced antistaphylococcal immune response, it was demonstrated that high-titer antistaphylococcal antibodies are stable for years in healthy individuals. In addition, we provide evidence obtained on the basis of opsonophagocytic and neutralizing activity in vitro assays that circulating antistaphylococcal serum antibodies in healthy donors are functional. In light of these data we suggest that proper serological analysis comparing the preexisting antibody repertoires of hospitalized patients with different outcomes for nosocomial staphylococcal infections could be extremely useful for the evaluation of candidate vaccine antigens in addition to protection data generated with animal models.Keywords
This publication has 69 references indexed in Scilit:
- Identification of enolase as a laminin-binding protein on the surface of Staphylococcus aureusMicrobes and Infection, 2004
- Anti-Clumping Factor A Immunoglobulin Reduces the Duration of Methicillin-ResistantStaphylococcus aureusBacteremia in an Experimental Model of Infective EndocarditisAntimicrobial Agents and Chemotherapy, 2003
- Passage of Heme-Iron Across the Envelope of Staphylococcus aureusScience, 2003
- Maintenance of Serological Memory by Polyclonal Activation of Human Memory B CellsScience, 2002
- Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureusProceedings of the National Academy of Sciences, 2002
- Use of aStaphylococcus aureusConjugate Vaccine in Patients Receiving HemodialysisNew England Journal of Medicine, 2002
- Functional Antibody Activity Elicited by Fractional Doses ofHaemophilus influenzaeType b Conjugate Vaccine (Polyribosylribitol Phosphate–Tetanus Toxoid Conjugate)Clinical and Diagnostic Laboratory Immunology, 2001
- A B Cell Superantigen–Induced Persistent “Hole” in the B-1 RepertoireThe Journal of Experimental Medicine, 2000
- Nosocomial infections in medical intensive care units in the United StatesCritical Care Medicine, 1999
- Chronic granulomatous disease in adultsThe Lancet, 1996